Malignant otitis externa: Evolving pathogens and implications for diagnosis and treatment

Candace E. Hobson, Jennifer D. Moy, Karin E. Byers, Yael Raz, Barry E. Hirsch, Andrew A. McCall

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective. Malignant otitis externa (MOE) is an invasive infection of the temporal bone that is classically caused by Pseudomonas aeruginosa. Increasingly, however, nonpseudomonal cases are being reported. The goal of this study was to evaluate and compare the clinical presentation and outcomes of cases of MOE caused by Pseudomonas versus non-Pseudomonas organisms.

Study Design. Retrospective case series with chart review.

Setting. Tertiary care institution.

Subjects and Methods. Adult patients with diagnoses of MOE between 1995 and 2012 were identified. Charts were reviewed for history, clinical presentation, laboratory data, treatment, and outcomes.

Results. Twenty patients diagnosed with and treated for MOE at the University of Pittsburgh Medical Center between 1995 and 2012 were identified. Nine patients (45%) had cultures that grew P aeruginosa. Three patients (15%) had cultures that grew methicillin-resistant Staphylococcus aureus (MRSA). Signs and symptoms at presentation were similar across groups. However, all of the patients with Pseudomonas had diabetes, compared with 33% of MRSA-infected patients (P = .046) and 55% of all non-Pseudomonas-infected patients (P = .04). Patients infected with MRSA were treated for an average total of 4.7 more weeks of antibiotic therapy than Pseudomonasinfected patients (P = .10). Overall, patients with non- Pseudomonas infections were treated for a total of 2.4 more weeks than Pseudomonas-infected patients (P = .25).

Conclusions. A high index of suspicion for nonpseudomonal organisms should be maintained in patients with signs and symptoms of MOE, especially in those without diabetes. MRSA is an increasingly implicated organism in MOE.

Original languageEnglish (US)
Pages (from-to)112-116
Number of pages5
JournalOtolaryngology - Head and Neck Surgery (United States)
Volume151
Issue number1
DOIs
StatePublished - Jul 27 2014
Externally publishedYes

Fingerprint

Otitis Externa
Methicillin-Resistant Staphylococcus aureus
Therapeutics
Pseudomonas
Signs and Symptoms
Pseudomonas Infections
Temporal Bone
Tertiary Healthcare
Pseudomonas aeruginosa

Keywords

  • malignant otitis externa
  • methicillin- resistant Staphylococcus aureus
  • MRSA
  • necrotizing otitis externa
  • otitis externa
  • Pseudomonas aeruginosa

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Malignant otitis externa : Evolving pathogens and implications for diagnosis and treatment. / Hobson, Candace E.; Moy, Jennifer D.; Byers, Karin E.; Raz, Yael; Hirsch, Barry E.; McCall, Andrew A.

In: Otolaryngology - Head and Neck Surgery (United States), Vol. 151, No. 1, 27.07.2014, p. 112-116.

Research output: Contribution to journalArticle

Hobson, Candace E. ; Moy, Jennifer D. ; Byers, Karin E. ; Raz, Yael ; Hirsch, Barry E. ; McCall, Andrew A. / Malignant otitis externa : Evolving pathogens and implications for diagnosis and treatment. In: Otolaryngology - Head and Neck Surgery (United States). 2014 ; Vol. 151, No. 1. pp. 112-116.
@article{06bd18917405494a8e086cd01911a968,
title = "Malignant otitis externa: Evolving pathogens and implications for diagnosis and treatment",
abstract = "Objective. Malignant otitis externa (MOE) is an invasive infection of the temporal bone that is classically caused by Pseudomonas aeruginosa. Increasingly, however, nonpseudomonal cases are being reported. The goal of this study was to evaluate and compare the clinical presentation and outcomes of cases of MOE caused by Pseudomonas versus non-Pseudomonas organisms.Study Design. Retrospective case series with chart review.Setting. Tertiary care institution.Subjects and Methods. Adult patients with diagnoses of MOE between 1995 and 2012 were identified. Charts were reviewed for history, clinical presentation, laboratory data, treatment, and outcomes.Results. Twenty patients diagnosed with and treated for MOE at the University of Pittsburgh Medical Center between 1995 and 2012 were identified. Nine patients (45{\%}) had cultures that grew P aeruginosa. Three patients (15{\%}) had cultures that grew methicillin-resistant Staphylococcus aureus (MRSA). Signs and symptoms at presentation were similar across groups. However, all of the patients with Pseudomonas had diabetes, compared with 33{\%} of MRSA-infected patients (P = .046) and 55{\%} of all non-Pseudomonas-infected patients (P = .04). Patients infected with MRSA were treated for an average total of 4.7 more weeks of antibiotic therapy than Pseudomonasinfected patients (P = .10). Overall, patients with non- Pseudomonas infections were treated for a total of 2.4 more weeks than Pseudomonas-infected patients (P = .25).Conclusions. A high index of suspicion for nonpseudomonal organisms should be maintained in patients with signs and symptoms of MOE, especially in those without diabetes. MRSA is an increasingly implicated organism in MOE.",
keywords = "malignant otitis externa, methicillin- resistant Staphylococcus aureus, MRSA, necrotizing otitis externa, otitis externa, Pseudomonas aeruginosa",
author = "Hobson, {Candace E.} and Moy, {Jennifer D.} and Byers, {Karin E.} and Yael Raz and Hirsch, {Barry E.} and McCall, {Andrew A.}",
year = "2014",
month = "7",
day = "27",
doi = "10.1177/0194599814528301",
language = "English (US)",
volume = "151",
pages = "112--116",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Malignant otitis externa

T2 - Evolving pathogens and implications for diagnosis and treatment

AU - Hobson, Candace E.

AU - Moy, Jennifer D.

AU - Byers, Karin E.

AU - Raz, Yael

AU - Hirsch, Barry E.

AU - McCall, Andrew A.

PY - 2014/7/27

Y1 - 2014/7/27

N2 - Objective. Malignant otitis externa (MOE) is an invasive infection of the temporal bone that is classically caused by Pseudomonas aeruginosa. Increasingly, however, nonpseudomonal cases are being reported. The goal of this study was to evaluate and compare the clinical presentation and outcomes of cases of MOE caused by Pseudomonas versus non-Pseudomonas organisms.Study Design. Retrospective case series with chart review.Setting. Tertiary care institution.Subjects and Methods. Adult patients with diagnoses of MOE between 1995 and 2012 were identified. Charts were reviewed for history, clinical presentation, laboratory data, treatment, and outcomes.Results. Twenty patients diagnosed with and treated for MOE at the University of Pittsburgh Medical Center between 1995 and 2012 were identified. Nine patients (45%) had cultures that grew P aeruginosa. Three patients (15%) had cultures that grew methicillin-resistant Staphylococcus aureus (MRSA). Signs and symptoms at presentation were similar across groups. However, all of the patients with Pseudomonas had diabetes, compared with 33% of MRSA-infected patients (P = .046) and 55% of all non-Pseudomonas-infected patients (P = .04). Patients infected with MRSA were treated for an average total of 4.7 more weeks of antibiotic therapy than Pseudomonasinfected patients (P = .10). Overall, patients with non- Pseudomonas infections were treated for a total of 2.4 more weeks than Pseudomonas-infected patients (P = .25).Conclusions. A high index of suspicion for nonpseudomonal organisms should be maintained in patients with signs and symptoms of MOE, especially in those without diabetes. MRSA is an increasingly implicated organism in MOE.

AB - Objective. Malignant otitis externa (MOE) is an invasive infection of the temporal bone that is classically caused by Pseudomonas aeruginosa. Increasingly, however, nonpseudomonal cases are being reported. The goal of this study was to evaluate and compare the clinical presentation and outcomes of cases of MOE caused by Pseudomonas versus non-Pseudomonas organisms.Study Design. Retrospective case series with chart review.Setting. Tertiary care institution.Subjects and Methods. Adult patients with diagnoses of MOE between 1995 and 2012 were identified. Charts were reviewed for history, clinical presentation, laboratory data, treatment, and outcomes.Results. Twenty patients diagnosed with and treated for MOE at the University of Pittsburgh Medical Center between 1995 and 2012 were identified. Nine patients (45%) had cultures that grew P aeruginosa. Three patients (15%) had cultures that grew methicillin-resistant Staphylococcus aureus (MRSA). Signs and symptoms at presentation were similar across groups. However, all of the patients with Pseudomonas had diabetes, compared with 33% of MRSA-infected patients (P = .046) and 55% of all non-Pseudomonas-infected patients (P = .04). Patients infected with MRSA were treated for an average total of 4.7 more weeks of antibiotic therapy than Pseudomonasinfected patients (P = .10). Overall, patients with non- Pseudomonas infections were treated for a total of 2.4 more weeks than Pseudomonas-infected patients (P = .25).Conclusions. A high index of suspicion for nonpseudomonal organisms should be maintained in patients with signs and symptoms of MOE, especially in those without diabetes. MRSA is an increasingly implicated organism in MOE.

KW - malignant otitis externa

KW - methicillin- resistant Staphylococcus aureus

KW - MRSA

KW - necrotizing otitis externa

KW - otitis externa

KW - Pseudomonas aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=84908670675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908670675&partnerID=8YFLogxK

U2 - 10.1177/0194599814528301

DO - 10.1177/0194599814528301

M3 - Article

C2 - 24675790

AN - SCOPUS:84908670675

VL - 151

SP - 112

EP - 116

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

IS - 1

ER -